Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$7.38 - $10.4 $6,494 - $9,152
-880 Closed
0 $0
Q2 2021

Jul 13, 2021

SELL
$9.9 - $11.56 $30,492 - $35,604
-3,080 Reduced 77.78%
880 $9,000
Q4 2020

Feb 17, 2021

BUY
$8.61 - $11.04 $34,095 - $43,718
3,960 New
3,960 $38,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Freedman Financial Associates, Inc. Portfolio

Follow Freedman Financial Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Freedman Financial Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Freedman Financial Associates, Inc. with notifications on news.